Navigation Links
U-M study: 'Smarter' blood pressure guidelines could prevent many more heart attacks and strokes
Date:11/4/2013

ANN ARBOR, Mich. A new way of using blood pressure-lowering medications could prevent more than a fourth of heart attacks and strokes up to 180,000 a year while using less medication overall, according to new research from the University of Michigan Health System and the VA Ann Arbor Healthcare System.

Individualizing treatment recommendations using patients' risk of heart disease after considering multiple factors such as age, gender and whether or not the patient smokes is a more effective way to treat patients than current methods, according to the study that appears in the medical journal, Circulation.

Current medical guidelines use a one-size-fits-all treatment approach based on target blood pressure values that leads to some patients being on too many medications and others being on too little, authors say.

Blood pressure medication is ultimately used to prevent associated heart disease and stroke. Researchers found that a person's blood pressure level is often not the most important factor in determining if a blood pressure medication will prevent these diseases but common practice is to base treatment strictly on blood pressure levels.

"Drugs that lower blood pressure are among the most effective and commonly used medications in the country, but we believe they can be used dramatically more effectively," says lead author Jeremy Sussman, M.D., M.Sc., assistant professor of internal medicine in the Division of General Medicine at the U-M Medical School and research scientist at the Center for Clinical Management Research at the VA Ann Arbor Healthcare System.

"The purpose of these medications is not actually to avoid high blood pressure itself but to stop heart attacks, strokes and other cardiovascular diseases. We should guide use of medications by a patient's risk of these diseases and how much adding a new medication decreases that risk not solely on their blood pressure level. We found that people who have mildly high blood pressure but high cardiovascular risk receive a lot of benefit from treatment, but those with low overall cardiovascular risk do not."

Current treatment guidelines emphasize specific blood pressure goals, with the majority of treatment driven specifically towards pushing blood pressure below 140/80 mmHg. However, authors say tailored blood pressure treatment decisions based on a patient's overall cardiovascular disease risk and the estimated benefits of advancing treatment is a substantially more effective model of care.

Authors say new blood pressure guidelines could help patients make informed decisions about their care. For example, if patients knew that medication only slightly reduced their risk of a heart attack or stroke (e.g. from 8 in 100 to 6 in 100 over the next 10 years), they may decide medication is not the right choice for them.

"In addition to resulting in more positive health outcomes for patients, this approach provides the type of information we need to guide individual decisions tailored to the patients' preferences and priorities," says senior author Rod Hayward, professor of Medicine and Public Health and senior investigator at the VA Center for Clinical Management Research.

"Our research shows how we can estimate how much taking more blood pressure medicine will reduce an individual's risk of heart disease and strokes, so that they and their doctor can make the best decision for them."

Both Sussman and Hayward are members of the U-M Institute for Healthcare Policy and Innovation and the Center for Clinical Management Research at Ann Arbor VA..


'/>"/>

Contact: Beata Mostafavi
bmostafa@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. IU study: Leadership void, not lack of money, slows efforts to address cervical cancer
2. New study: Enterocystoplasty in children with genitourinary abnormalities is safe and effective
3. Mayo Clinic study: Uterine fibroids have significant impact on quality of life, workplace performance
4. Rice U study: Technology, not uninsured patients, driving hospital costs
5. CU Cancer Center study: Young patients with metastatic colorectal cancer at higher risk
6. Study: New medical device extremely effective at preventing HIV in women
7. Penn Medicine study: Proton therapy cuts side effects for pediatric head and neck cancer patients
8. Study: Majority of patients who qualify for lifesaving heart treatment do not receive it
9. Mayo-led study: Drug fails to reduce diarrhea in patients receiving radiation therapy
10. Study: Memory problems, emotional stress result in early readmissions of heart patients
11. Study: Redefining the Criteria for ALK Positive Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: